Bloomberg Law  |  July 17, 2020

One health scholar said these short-term products are likely to raise premiums in the ACA marketplace for people with pre-existing conditions and could end up hurting patients who are enrolled in short-term plans during the Covid-19 pandemic. “I think it’s both bad for patients and for the broader insurance market,” said Katie Keith, a health law professor at Georgetown University.

Read more here.